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ABSTRACT
Objective: The incidence of new-onset diabetes
after transplantation (NODAT) and premature
mortality is high in renal transplant recipients (RTR).
We hypothesized that a Mediterranean Style diet
protects against NODAT and premature mortality in
RTR.
Research design and methods: A prospective
cohort study of adult RTR with a functioning graft
for >1 year. Dietary intake was assessed with a 177-
item validated food frequency questionnaire. Patients
were divided based on a 9-point Mediterranean Style
Diet Score (MDS): low MDS (0–4 points) versus
high MDS (5–9 points). A total of 468 RTR were
eligible for analyses. Logistic multivariable
regression analyses were used to study the
association of MDS with NODAT and Cox
multivariable regression models for the association
with all-cause mortality.
Results: Mean±SD age was 51.3±13.2 years and
56.6% were men. About 50% of the patients had a
high MDS. During median follow-up of 4.0 (IQR,
0.4–5.4) years, 22 (5%) RTR developed NODAT and
50 (11%) died. High MDS was significantly
associated with both a lower risk of NODAT
(HR=0.23; 95% CI 0.09 to 0.64; p=0.004) and all-
cause mortality (HR=0.51; 95% CI 0.29 to 0.89,
p=0.02) compared to low MDS, independent of age
and sex. Adjustment for other potential confounders,
including total energy intake, physical activity and
smoking status, did not materially change the results
of the analyses.
Conclusions: Dietary habits leading to high MDS
were associated with lower risk of NODAT. These
results suggest that healthy dietary habits are of
paramount importance for RTR.
INTRODUCTION
The prevalence of patients with end-stage
renal disease for which patients require
chronic dialysis or renal transplantation, also
called renal replacement therapy, is increas-
ing at a rate of 7% per year.1 Renal trans-
plantation improves quality of life and
increases survival, compared to dialysis
treatment.2 3 However, the results are not
impressive, since a lot of factors impair sur-
vival after renal transplantation. One of these
factors is new-onset diabetes after transplant-
ation (NODAT), which is caused by the com-
bination of insulin resistance and deﬁcient
insulin production.4 The incidence of
NODAT is high and affects ∼20% of renal
transplant recipients (RTR).5 However, a sys-
temic review of Montori et al6 concluded that
the incidence of NODAT varied widely from
2% to 50% in the ﬁrst post-transplant year,
due to inconsistencies regarding the deﬁn-
ition of NODAT. NODAT is an important risk
factor for premature mortality in RTR.7 8
This can partly be explained by the fact that
NODAT contributes to a high cardiovascular
risk, infectious complications and impaired
graft survival in RTR.9–11
Patients with end-stage renal disease are
often advised to consume a low protein, low
potassium, low sodium diet, which is also
often restricted in ﬂuid intake, causing a
diet high in energy-rich drinks, carbohy-
drates and fats to get enough energy.12 This
diet prevents excessive generation of urea
and the occurrence of hyperphosphatemia,
hyperkalemia and hypertension. However, a
low-protein diet gives little satiety,13 and
adherence to this dietary pattern may induce
problems once combined with the
Key messages
▪ Renal transplant recipients are at high risk for
development of new-onset diabetes after trans-
plantation and premature mortality.
▪ Dietary habits consistent with a Mediterranean
style diet are associated with lower risk of devel-
opment of new-onset diabetes after transplant-
ation and premature mortality in renal transplant
recipients.
▪ These lower risks were independent of potential
confounders, including age, sex, physical activity
and smoking behavior.
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stimulation of appetite. This may be a consequence of
improved renal function after renal transplantation and
as a side effect of the corticosteroid treatment that is
part of the immunosuppressive regimen after renal
transplantation.14 Furthermore, RTR have low levels of
physical activity and gain fat mass after transplantation,
resulting in obesity in 26% of the participants,12 an inde-
pendent risk factor for the development of NODAT.9 To
reduce the incidence of NODAT and improve overall
transplant success, more attention should be paid to life-
style modiﬁcation.
Meta-analyses showed that adherence to the
Mediterranean diet was associated with a lower risk of
diabetes.15 16 Furthermore, Estruch et al17 showed in
the PREDIMED trial that two components of the
Mediterranean diet (additional amount of extra virgin
olive oil and nuts) reduced the incidence of cardiovascu-
lar events among high-risk patients. In the present study,
we aimed to investigate the association of Mediterranean
Style diet with the incidence of NODAT and all-cause
mortality in RTR that has not yet been examined. We
hypothesized that a Mediterranean Style diet is asso-
ciated with a lower risk of NODAT and all-cause mortal-
ity in RTR.
RESEARCH DESIGN AND METHODS
Study design and population
The study design of this research project is a large
single-center prospective cohort of RTR. All adult RTR
(≥18 years) with a functioning graft for at least 1 year
who visited the outpatient clinic in the University
Medical Center Groningen between November 2008
and May 2011 were invited to participate. Patients were
only included if this visit was at least 1 year after trans-
plantation. All patients had sufﬁcient knowledge of the
Dutch language and according to their patient ﬁles and
no history of drug or alcohol addiction. In total 707
(86.5%) of the initially 817 invited RTR signed a written
informed consent. RTR with missing dietary data
(n=81), diabetes mellitus (DM) at baseline (n=152) or
who underwent combined pancreas-kidney transplant-
ation (n=6) were excluded, leaving 468 RTR eligible for
analyses. This research project was approved by the insti-
tutional review board (METc 2008/186), which adhered
to the Declaration of Helsinki.
Data collection and clinical end points
Baseline data were collected during a morning visit to
the outpatient clinic as described previously.18 19 Body
weight and height were measured while participants
wore indoor clothing without shoes. Waist and hip cir-
cumference were measured. Both systolic blood pressure
and diastolic blood pressure and also heart rate were
measured using a semiautomatic device (Dinamap1846;
Critikon, Tampa, Florida, USA). They were measured
every minute for 15 min in a half-sitting position to
prevent white coat hypertension. Information about
daily physical activity was derived using the Short
QUestionnaire to ASsess Health-enhancing physical activ-
ity (SQUASH) score in time multiplied by intensity.20
Information about smoking behavior was obtained by
using a questionnaire. Medication use was acquired from
patient records. Furthermore, fasting blood samples
were collected and patients were also asked to complete
24 hour urine collection. All RTR were informed to
discard their morning urine specimen and then collect
their urine for the next 24 hours, including the next
morning’s ﬁrst specimen of the day of their visit.
Creatinine clearance was based on 24 hour urinary
creatinine and serum creatinine. Estimated glomerular
ﬁltration rate was calculated using the serum creatinine-
based Chronic Kidney Disease Epidemiology
Collaboration equation.21
A semiquantitative food frequency questionnaire
(FFQ) was used to collect information on dietary intake
at baseline during the past month. The FFQ was devel-
oped at Wageningen University22 and consisted of 177
items. Patients ﬁlled out the self-administered FFQ at
home. Frequency was recorded in times per day, week or
month for each item. Expression of number of servings
was in either natural units such as a slice of bread or an
apple, or in household measures, for example, a cup or
a teaspoon. Subsequently, all dietary data were converted
into total energy and nutrient intake per day using the
Dutch Food Composition Table (NEVO 2006). The FFQ
was validated by comparing the protein intake of the
FFQ with the protein intake calculated by the Maroni
Equation, using urinary urea excretion values.19 Protein
intake was similar to the estimates derived from the
FFQ.23
The degree to which the consumed diet resembled
the traditional Mediterranean diet was calculated
according to a nine-point Mediterranean Diet Score
(MDS) of Trichopoulou et al.24 The MDS includes nine
food groups: ratio of monounsaturated:saturated fatty
acids, intake of legumes, cereals, vegetables, fruit, ﬁsh,
dairy products, meat products and alcohol.9 14 Food
items of the FFQ were divided over these nine food
groups (see online supplementary table S1). For each
food group, the sex-speciﬁc median in grams per day
was used as cut-off point for making this division, except
for ﬁsh and alcohol. Patients received a score of 1 for
each of the putative protective components (ratio of
monounsaturated:saturated fatty acids, legumes, cereals,
vegetables, fruit) if their intake was above the median.
The traditional Mediterranean diet was low in dairy and
meat products. Therefore, an intake below the median
for these food groups was scored 1 and for an intake
above the median 1. For the ﬁsh component partici-
pants received a score of 1 if they consumed more than
5 g/day and a score of 0 if they consumed <5 g/day
(<once a month). Alcohol users received a score of 1
and non-users received a score of 0. Moderate alcohol
intake is associated with low prevalence of NODAT and
lower risk for mortality in RTR, when compared to
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abstainers.25 The MDS varies between 0 (lowest adher-
ence) and 9 (highest adherence). Subsequently, all
patients were divided into two groups based on the fre-
quency distribution of the MDS: group 1 (MDS 0–4)
and group 2 (MDS 5–9). We dichotomized data because
of the small number of events.
In this study primary outcome measurements are the
incidence of NODAT and all-cause mortality. Care-based
data about the incidence of NODAT and mortality after
baseline were retrieved from patient ﬁles of all RTR
until 1 April 2014. NODAT was deﬁned as a fasting
plasma glucose level ≥7.0 mmol/L and/or use of oral
hypoglycemic agents or insulin therapy for ≥30 consecu-
tive days.26 Patients developed NODAT when they had
one or more of the following conditions; the patient was
diagnosed with DM, used antidiabetics (oral hypogly-
cemic agents or insulin therapy) and/or had a fasting
plasma glucose level ≥7.0 mmol/L or non-fasting
glucose level ≥11.1 mmol/L. The diagnosis of NODAT
was made in outpatient and clinical routine. Patients
were tested repeatedly before the diagnosis of NODAT
was made and treatment was started. No participants
were lost to follow-up.
Data on use of diuretics and/or β blockers, use of
ACE-inhibitors or angiotensin II receptor blocker, use of
statins, prevalence of polycystic kidney disease and
nephrosclerosis, previous viral infections (hepatitis C
and cytomegalovirus), cumulative dose of steroids before
inclusion, but during follow-up, incidence of acute rejec-
tion episodes during follow-up and used of mTOR inhi-
bitors at baseline and during follow-up were retrieved
from individual patient ﬁles. Cumulative dose of prednis-
olone was calculated as the sum of maintenance dose of
prednisolone until inclusion and the dose of prednisol-
one or methylprednisolone required for treatment of
acute rejection (a conversion factor of 1.25 was used
to convert methylprednisolone dose to dose of
prednisolone).
Statistical analyses
Variable distribution was tested with histograms and
probability (Q-Q) plots. For descriptive statistics, data
are presented as mean and SD when normally distribu-
ted, median and IQR when skewed distributed and
number and percentage in case of categorical data.
Differences between the two MDS groups to test for
potential confounders were tested by an unpaired t-test
for continuous variables with a normal distribution,
Mann-Whitney U test for continuous variables with a
skewed distribution and by means of a χ2 test for cat-
egorical variables. All statistical analyses were performed
using IBM Statistics SPSS V.22.0. For all statistical tests a
statistical signiﬁcance level of p≤0.05 (two-tailed) was
used. GraphPad Prism 5 was used to generate the
ﬁgures.
Primary analyses concerned Kaplan-Meier curves of
the incidence of NODAT and all-cause mortality. For
NODAT multivariable logistic regression models were
used because the exact dates when patients developed
an event were not exactly known. For multivariable Cox
regression models patients were censored at the date of
last follow-up or death. Owing to the small number of
NODAT and all-cause mortality the models were ﬁrst
adjusted for age and sex and additionally for more than
two potential confounders.27 Models were checked for
fulﬁllment of the assumptions for logistic regression and
Cox regression, including the proportional hazards
assumption. The assumptions were met.
RESULTS
In total 468 RTR (56.6% men) were included with a
mean±SD age of 51.3±13.2 years. The frequency dis-
tribution of the MDS in these 468 RTR is presented in
ﬁgure 1. The MDS varied between 0 (lowest adherence)
and 9 (highest adherence), with a mean score of 4.8±1.7
and 54% of the patients had a high score (>4). Baseline
characteristics of the overall RTR population and accord-
ing to high versus low MDS are shown in table 1. Age
and physical activity differed signiﬁcantly between the
groups. Patients with a high MDS were older, had a
higher physical activity score, lower fasting triglycerides
and higher high-density lipoprotein (HDL)-cholesterol
concentrations compared to patients with a low MDS.
The percentage of smokers and total energy intake did
not differ. A borderline statistical signiﬁcance was found
for pre-emptive transplantation, cold ischemia time and
use of tacrolimus.
Median time between baseline and transplantation
was 5.6 (IQR, 2.1–12.3) years. During a median
follow-up of 4.0 (IQR, 0.4–5.4) years from baseline, 22
(5%) patients developed NODAT (17 RTR in low MDS
group, 5 RTR in high MDS group) and 50 (11%)
patients died (29 RTR in low MDS group, 21 RTR in
high MDS group). In the low MDS group, 15 (88%) of
Figure 1 Frequency distribution of the Mediterranean Diet
Score (MDS) in the overall RTR population (468 participants).
RTR, renal transplant recipients.
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Table 1 Baseline characteristics of the overall RTR population and according to groups based on the MDS
Overall RTR
(n=468)
Group 1 MDS 0–4
(n=217)
Group 2 MDS 5–9
(n=251) p Value
Demographics
Age, years 51.3±13.2 49.9±13.9 52.5±12.4 0.03
Male gender, n (%) 265 (56.6) 124 (57.1) 141 (56.2) 0.83
Smoking behavior (current smoker), n (%) 60 (12.8) 29 (13.4) 31 (12.4) 0.64
Total energy intake, kcal/day 2199±656 2168±696 2225±619 0.35
Physical activity score (time×intensity) 5605 (2885–8647) 5060 (2070–8385) 6000 (3480–8700) 0.03
Weight, kg 78.9±15.8 78.1±16.2 79.6±15.5 0.31
Body composition
Height, cm 173.9±9.7 173.4±10.6 174.3±9.0 0.30
BMI, kg/m2 26.0±4.5 25.9±4.6 26.1±4.5 0.60
Waist circumference, cm
Men 99.1±12.1 98.7±12.2 99.5±12.1 0.98
Women 93.0±15.8 92.6±15.3 93.4±16.3 0.68
Circulation
Heart rate, bpm 67.6±12.0 67.8±12.3 67.4±11.8 0.72
SBP, mm Hg 135.3±17.0 135.7±16.3 135.0±17.7 0.68
DBP, mm Hg 83.0±11.0 83.3±11.1 82.8±11.0 0.61
Renal function
eGFR, mL/min per 1.73 m2 53.1±20.2 52.3±21.6 53.7±18.8 0.45
Laboratory parameters
Triglycerides, mmol/L 1.6 (1.2–2.1) 1.7 (1.2–2.3) 1.5 (1.1–2.0) 0.04
HDL cholesterol, mmol/L 1.4±0.5 1.4±0.4 1.5±0.5 0.001
Fasting glucose, mmol/L 5.1 (4.7–5.5) 5.1 (4.7–5.5) 5.0 (4.7–5.5) 0.51
Hepatitis C virus, n (%) 6 (1.3) 3 (1.4) 3 (1.2) 0.86
Cytomegalovirus, n (%)
Primary infection 99 (21.2) 48 (22.1) 51 (20.3) 0.63
Reactivation 80 (17.1) 38 (17.5) 42 (16.7) 0.69
Primary renal disease
Polycystic kidney disease, n (%) 103 (22.0) 47 (21.7) 56 (22.3) 0.87
Nephrosclerosis, n (%) 139 (29.7) 67 (30.9) 72 (28.7) 0.61
Transplant characteristics
Transplant vintage, years 5.6 (2.1–12.3) 5.2 (2.2–12.3) 5.8 (1.8–12.3) 0.80
Living donor, n (%) 168 (35.9) 70 (32.3) 98 (39.0) 0.20
Pre-emptive transplant, n (%) 84 (17.9) 32 (14.7) 52 (20.7) 0.09
Dialysis duration, months 37.0 (16.0–60.0) 46.0 (15.0–63.0) 32.0 (17.0–56.0) 0.30
Age donor, years 43.0±15.5 42.6±15.0 43.4±15.9 0.61
Cold ischemia time, hours 14.0 (3.0–21.0) 16.0 (3.0–21.0) 12.0 (3.0–21.0) 0.06
Warm ischemia time, minutes 40 (33–50) 42 (33–51) 39 (34–48) 0.25
Acute rejection, n (%) 114 (24.4) 49 (22.6) 65 (25.9) 0.41
Medication
Cyclosporine, n (%) 178 (38.0) 82 (37.8) 96 (38.2) 0.92
Tacrolimus, n (%) 79 (16.9) 44 (20.3) 35 (13.9) 0.07
mTOR inhibitor, n (%) 5 (1.1) 2 (0.9) 3 (1.2) 0.76
Prednisolone dose, mg 10.0 (7.5–10.0) 10.0 (7.5–10.0) 10.0 (7.5–10.0) 0.70
Cumulative prednisolone dose, g 18.3 (7.4–38.1) 18.3 (7.8–36.6) 18.2 (7.4–40.4) 0.86
Diuretics, n (%) 158 (33.8) 76 (35.0) 82 (32.7) 0.59
β blocker, n (%) 284 (60.7) 126 (58.1) 158 (62.9) 0.28
ACE inhibitor, n (%) 158 (33.8) 73 (33.6) 85 (33.9) 0.96
Angiotensin II receptor blocker, n (%) 71 (15.2) 39 (18.0) 32 (12.7) 0.12
Statins, n (%) 232 (49.6) 100 (46.1) 132 (52.6) 0.15
Data are represented as mean±SD, median (IQR) or n (%). Differences were tested by t-test or Mann-Whitney U test for continuous variables
and with χ2 test for categorical variables.
BMI, body mass index; DBP, diastolic blood pressure; eGFR, estimated glomerular filtration rate; HDL, high-density lipoprotein; MDS,
Mediterranean Diet Score; RTR, renal transplant recipients; SBP, systolic blood pressure.
4 BMJ Open Diabetes Research and Care 2017;5:e000283. doi:10.1136/bmjdrc-2016-000283
Clinical care/education/nutrition/psychosocial research
group.bmj.com on May 4, 2017 - Published by http://drc.bmj.com/Downloaded from 
the RTR that developed NODAT required treatment
with hypoglycemic agents or insulin and in the high
MDS group, 5 (100%) of the RTR that developed
NODAT required treatment with hypoglycemic agents or
insulin. Median intake for the nine food groups of the
MDS for both men and women are shown in table 2. In
the low MDS group men had a higher intake of cereals
and alcohol, whereas women had a higher intake of
fruit. In the high MDS group men had a higher intake
of cereals, whereas women had a high intake of fruit
and vegetables. Intake of other food groups is approxi-
mately equal between male and female RTR. The high
MDS group had a higher intake of legumes, cereals,
vegetables, fruit, ﬁsh and alcohol compared to the low
MDS group.
The Kaplan-Meier survival curves for the associations
of the MDS with NODAT (p=0.003, log rank test) and
all-cause mortality (p=0.09, log rank test) are shown in
ﬁgure 2. RTR with MDS scores ≥5 points were signiﬁ-
cantly associated with a lower risk of NODAT (OR: 0.23;
95% CI 0.09 to 0.64; p=0.004) and all-cause mortality
(hazards ratio (HR): 0.51; 95% CI 0.29 to 0.89, p=0.02),
adjusted for age and sex (tables 3 and 4). The results of
multivariable analyses, in which we additionally adjusted
for use of medication, pre-emptive transplantation and
cold ischemia time, total energy intake, smoking
behavior and physical activity, fasting triglycerides and
HDL-cholesterol concentrations and time between trans-
plantation and baseline, did not materially change the
results of the analyses adjusted for age and sex (tables 3
and 4).
CONCLUSIONS
About 50% of the RTR had either a low or a high MDS.
Patients with a high MDS had a four times lower risk of
NODAT and a two times lower risk of all-cause mortality.
These results suggest that a healthy diet is of paramount
importance for patients who receive a new kidney.
Previous studies on diet and chronic diseases often
focused on single nutrients. However, food-based dietary
patterns take into account complex interactions between
food items and are easier to interpret. Another advan-
tage of foods and dietary patterns is that they can dir-
ectly be transplanted into dietary recommendations to
be used in clinical practice.28 29
A meta-analysis of population-based prospective
cohort studies showed that greater adherence to the
Mediterranean Style diet was associated with a 20%
lower all-cause mortality30 and 20% lower cardiovascular
risk.31 A meta-analysis of the adherence to the
Mediterranean Style diet showed a 25% lower incidence
of diabetes mellitus among prospective cohort studies.15





Men Women Men Women
Ratio monounsaturated: saturated fatty acids 0.9 (0.8–1.0) 0.9 (0.8–1.0) 1.0 (0.9–1.1) 1.0 (0.9–1.1)
Legumes, nuts and soy products (g/day) 29 (16–39) 28 (18–40) 52 (38–72) 44 (32–71)
Cereals (g/day) 176 (128–240) 134 (107–178) 210 (170–257) 175 (141–206)
Fruit (g/day) 77 (34–137) 105 (57–211) 135 (81–234) 211 (97–249)
Vegetables (g/day) 57 (32–77) 64 (48–87) 100 (74–140) 124 (92–153)
Meat products (g/day) 109 (82–128) 94 (77–116) 90 (70–115) 79 (58–99)
Dairy products (g/day) 357 (234–511) 399 (253–492) 330 (211–481) 369 (217–507)
Fish (%) 34 34 57 67
Alcohol (%) 67 84 48 80
Figure 2 Kaplan-Meier survival
curves. Probability of survival for
NODAT (A) and all-cause
mortality (B) for both group 1 and
group 2. NODAT, new-onset
diabetes after transplantation.
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To the best of our knowledge, this is the ﬁrst study to
investigate the association between a Mediterranean
Style diet and risk of NODAT and all-cause mortality in
RTR. In line with our results on NODAT another study
showed an association between adherence to a
Mediterranean Style diet and a lower incidence of meta-
bolic syndrome after transplantation.32 Prospective
cohort studies among patients with cardiovascular
disease showed that a Mediterranean Style diet was asso-
ciated with a lower risk of all-cause mortality.33–35 These
results suggest that a Mediterranean Style diet is asso-
ciated with a lower mortality risk in patients with renal
transplant and also in patients with cardiovascular
disease. This shows the great potential of a healthy diet
in secondary prevention.
There are multiple mechanisms that might explain
the protective effect of a Mediterranean Style diet on
the development of NODAT and mortality in RTR. It is
well known that insulin resistance and pancreatic β cell
dysfunction are two fundamental features that play an
important role in the development of type 2 DM.36 High
adherence to the Mediterranean Style diet is associated
with a higher intake of antioxidants, dietary ﬁber,
magnesium and unsaturated fatty acids.36 The
Mediterranean diet may prevent cardiometabolic dis-
eases through several pathways. First of all, prolonged
oxidative stress contributes to the development of
insulin resistance and pancreatic β-cell dysfunction.37 A
Mediterranean Style diet might have a protective effect
on oxidative stress and antioxidant defense, since this
dietary pattern is characterized by high intake of fruit
and vegetables.38 Second, the high intake of dietary
ﬁber might reduce plasma insulin levels and have an
advantageous effect on glucose metabolism.36 Third,
magnesium might play an important role in preventing
type 2 DM.36 Previous studies showed that high intake of
magnesium is associated with a lower risk of developing
type 2 diabetes.39 40
Also fatty acids could play a role in the prevention of
cardiometabolic diseases. A high ratio of monounsatu-
rated: saturated fatty acids improves insulin sensitivity.41
A high intake of monounsaturated fatty acids beneﬁts
glycemic control, since it stimulates the secretion of
glucagon-like peptide-1 (GLP-1), an antidiabetic
hormone.42 GLP-1 activates the GLP-1 receptor in the
pancreatic islets, which leads to an increase in secretion
of insulin and inhibition of glucagon.43 Furthermore,
GLP-1 plays a role in satiety.44
Finally, pathological processes as inﬂammation and
endothelial dysfunction play a role in the etiology of car-
diovascular events.45 46 A previous study showed that
higher adherence to a Mediterranean Style diet is asso-
ciated with a lower concentration of biomarkers for inﬂam-
mation and endothelial dysfunction; C reactive protein,
interleukin-6, E-selectin and soluble intercellular cell adhe-
sion molecule-1.47 Furthermore, the literature shows that
olive oil, vegetables, cereals and nuts have antithrombotic
and/or anticoagulant effects.46 Adherence to a
Mediterranean Style diet is associated with lower levels of
prothrombotic biomarkers, for example, ﬁbrogen,48 which
contributes to a lower cardiovascular risk as well.
Table 3 Multiple logistic regression analysis
Group 1 (0–4) Group 2 (5–9)
17 (7.8%) 5 (2.0%)
Number of
events OR (95% CI) p Value
Model 1 1.00 (ref) 0.24 (0.09 to 0.66) 0.006
Model 2 1.00 (ref) 0.23 (0.08 to 0.63) 0.004
Model 3 1.00 (ref) 0.22 (0.08 to 0.62) 0.004
Model 4 1.00 (ref) 0.24 (0.08 to 0.69) 0.008
Model 5 1.00 (ref) 0.23 (0.08 to 0.63) 0.004
Model 6 1.00 (ref) 0.23 (0.08 to 0.65) 0.005
Model 7 1.00 (ref) 0.18 (0.06 to 0.54) 0.002
Model 8 1.00 (ref) 0.23 (0.08 to 0.63) 0.004
The Mediterranean diet is associated with a lower risk to develop
NODAT.
Model 1, crude.
Model 2, adjustment for age and sex.
Model 3, model 2+adjustment for cyclosporine, tacrolimus and
prednisolone dose.
Model 4, model 2+adjustment for pre-emptive transplantation and
cold ischemia time.
Model 5, model 2+adjustment for total energy intake.
Model 6, model 2+adjustment for smoking and physical activity.
Model 7, model 2+adjustment for triglycerides and
HDL-cholesterol concentrations.
Model 8, model 2+adjustment for time between transplantation
and baseline.
HDL, high-density lipoprotein; NODAT, new-onset diabetes after
transplantation.
Table 4 Cox Regression analysis
Group 1 (0–4) Group 2 (5–9)
29 (13.4%) 21 (8.4%)
Number of
events HR (95% CI) p Value
Model 1 1.00 (ref) 0.62 (0.35 to 1.09) 0.09
Model 2 1.00 (ref) 0.51 (0.29 to 0.89) 0.02
Model 3 1.00 (ref) 0.52 (0.29 to 0.92) 0.03
Model 4 1.00 (ref) 0.52 (0.27 to 0.99) 0.05
Model 5 1.00 (ref) 0.51 (0.29 to 0.89) 0.02
Model 6 1.00 (ref) 0.57 (0.22 to 1.03) 0.06
Model 7 1.00 (ref) 0.57 (0.32 to 1.02) 0.06
Model 8 1.00 (ref) 0.50 (0.29 to 0.89) 0.02
The Mediterranean diet is associated with a lower risk of mortality
during follow-up.
Model 1, crude.
Model 2, adjustment for age and sex.
Model 3, model 2+adjustment for cyclosporine, tacrolimus and
prednisolone dose.
Model 4, model 2+adjustment for pre-emptive transplantation and
cold ischemia time.
Model 5, model 2+adjustment for total energy intake.
Model 6, model 2+adjustment for smoking and physical activity.
Model 7, model 2+adjustment for triglycerides and
HDL-cholesterol concentrations.
Model 8, model 2+adjustment for time between transplantation
and baseline.
HDL, high-density lipoprotein.
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Our study has several limitations. Although this is a
prospective cohort study, causality of the associations
cannot be assumed, since this study is of observational
nature. Also the number of NODAT cases and the
number of deaths is small. Furthermore, the FFQ was
originally developed to examine protein intake in RTR.
It was only validated by comparing the protein intake of
the FFQ with the protein intake calculated by the
Maroni Equation, using urinary urea excretion values.19
The Mediterranean Style diet of our RTR is not optimal
and may further lower the risk of NODAT and all-cause
mortality through a better adherence to the traditional
Mediterranean diet. It is the ﬁrst time the association
between the Mediterranean Style diet and NODAT and
all-cause mortality is investigated in RTR. Furthermore,
strengths include a complete follow-up of the clinically
relevant end points: NODAT and all-cause mortality.
In conclusion, our prospective cohort study suggests
that higher adherence to a Mediterranean Style diet
may prevent the development of NODAT and all-cause
mortality in RTR. More attention is needed for the
nutritional habits of RTR.
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